Organon & Co. (OGN) Earnings Call Analysis
NYSE · Healthcare · Drug Manufacturers - General
7/25
Growth 0
Margin 2
Expansion 2
Platform 0
Financial 3
latest quarter score
Earnings Reports
- 7
- 8
- 15
- 16